BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27446352)

  • 1. Splicing variants of ADAR2 and ADAR2-mediated RNA editing in glioma.
    Fu Y; Zhao X; Li Z; Wei J; Tian Y
    Oncol Lett; 2016 Aug; 12(2):788-792. PubMed ID: 27446352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
    Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
    Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new strategy to increase RNA editing at the Q/R site of GluA2 AMPA receptor subunits by targeting alternative splicing patterns of ADAR2.
    Chaytow H; Sethw Hassan I; Akbar S; Popplewell L; Dickson G; Chen PE
    J Neurosci Methods; 2021 Dec; 364():109357. PubMed ID: 34536489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing.
    Wei J; Li Z; Du C; Qi B; Zhao X; Wang L; Bi L; Wang G; Zhang X; Su X; Pan Y; Tian Y
    Acta Neurochir (Wien); 2014 Jun; 156(6):1135-42. PubMed ID: 24509948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
    Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
    Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
    Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
    Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: conservation and diversity in editing site sequence and alternative splicing patterns.
    Slavov D; Gardiner K
    Gene; 2002 Oct; 299(1-2):83-94. PubMed ID: 12459255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of alternative splicing by RNA editing.
    Rueter SM; Dawson TR; Emeson RB
    Nature; 1999 May; 399(6731):75-80. PubMed ID: 10331393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Enzymatic Activity of Rat ADAR2 Splicing Variants Is Due to Altered Capability to Interact with RNA in the Deaminase Domain.
    Filippini A; Bonini D; Giacopuzzi E; La Via L; Gangemi F; Colombi M; Barbon A
    Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29419780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA editing and alternative splicing: the importance of co-transcriptional coordination.
    Laurencikiene J; Källman AM; Fong N; Bentley DL; Ohman M
    EMBO Rep; 2006 Mar; 7(3):303-7. PubMed ID: 16440002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered RNA editing in mice lacking ADAR2 autoregulation.
    Feng Y; Sansam CL; Singh M; Emeson RB
    Mol Cell Biol; 2006 Jan; 26(2):480-8. PubMed ID: 16382140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.
    Hosaka T; Tsuji H; Kwak S
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mismatch on binding of ADAR2/GluR-2 pre-mRNA complex.
    Yang J; Song J; Zhang JZ; Ji C
    J Mol Model; 2015 Sep; 21(9):222. PubMed ID: 26252972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.
    Hosaka T; Yamashita T; Teramoto S; Hirose N; Tamaoka A; Kwak S
    Neurosci Res; 2019 Oct; 147():48-57. PubMed ID: 30448461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated intronic editing of
    Chen YT; Chang IY; Liu H; Ma CP; Kuo YP; Shih CT; Shih YH; Kang L; Tan BC
    J Biol Chem; 2018 Jun; 293(26):10158-10171. PubMed ID: 29769310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of developmental expression of the RNA editing enzyme rADAR2.
    Paupard M-C ; O'Connell MA; Gerber AP; Zukin RS
    Neuroscience; 2000; 95(3):869-79. PubMed ID: 10670454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel exon of mammalian ADAR2 extends open reading frame.
    Maas S; Gommans WM
    PLoS One; 2009; 4(1):e4225. PubMed ID: 19156214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRSF9 selectively represses ADAR2-mediated editing of brain-specific sites in primates.
    Shanmugam R; Zhang F; Srinivasan H; Charles Richard JL; Liu KI; Zhang X; Woo CWA; Chua ZHM; Buschdorf JP; Meaney MJ; Tan MH
    Nucleic Acids Res; 2018 Aug; 46(14):7379-7395. PubMed ID: 29992293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of RNA editing by functional nucleolar sequestration of ADAR2.
    Sansam CL; Wells KS; Emeson RB
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14018-23. PubMed ID: 14612560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.